Morgans downgrades Nufarm Limited (NUFMF) to a Hold
Confident Investing Starts Here:
Moore covers the Basic Materials sector, focusing on stocks such as Orica Limited, Incitec Pivot , and Nufarm Limited. According to TipRanks, Moore has an average return of 5.1% and a 53.57% success rate on recommended stocks.
In addition to Morgans, Nufarm Limited also received a Hold from Morgan Stanley's Andrew Scott in a report issued today. However, on the same day, Bell Potter maintained a Buy rating on Nufarm Limited (Other OTC: NUFMF).
The company has a one-year high of $3.58 and a one-year low of $1.97. Currently, Nufarm Limited has an average volume of 130.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
3 hours ago
- Business Wire
POSaBIT Reports Second Quarter 2025 Financial Results
TORONTO & SEATTLE--(BUSINESS WIRE)-- POSaBIT Systems Corporation (CSE: PBIT, OTC: POSAF) (the 'Company' or 'POSaBIT'), a leading provider of payments infrastructure in the cannabis industry, today announced its financial results for the three months ended June 30, 2025. 'POSaBIT delivered a historic quarter, announcing quarterly highs in Adjusted EBITDA of nearly $800 thousand dollars, Adjusted Gross Profit Margin of 78%, and the increasing of our cash on hand,' said Ryan Hamlin, co-founder and CEO of POSaBIT. 'We have reached a noteworthy time at POSaBIT, thanks to all our hard work and emphasis we have been putting on merchant growth and company profits – we are thrilled to be able to share our strong results with our investors this quarter. We are poised for continued growth this year and beyond by adding cash to our balance sheet and increasing our net profits.' Hamlin added, 'It is unfortunate that our stock price has not been reflective of our great results as we continue to focus on growth and profits. We are confident that market participants will soon realize the full opportunity and potential of POSaBIT. With the potential of rescheduling now on the horizon, POSaBIT is well positioned to take advantage of what we expect to be a huge uplift to the industry and POSaBIT's overall growth.' Recent Operational Highlights The POSaBIT eComm online menu continues to see positive growth – with over 75% of all new Point of Sale merchants opting to use the eComm online menu vs. a competing solution. POSaBIT reduced the outstanding accounts payable balance quarter over quarter – reflecting the focus put on paying down our debt while increasing our cash. Board and insiders acquired over a half a million shares on the open market in July 2025. Balance Sheet Financial Results The following table reconciles Revenue, as reported, to Adjusted Revenue for the quarter ended June 30, 2025 vs. June 30, 2024: in US Dollars June 30, 2025 June 30, 2024 Revenue, as reported $2,653,328 $4,077,820 Add: Cash receipts from licensing contracts $1,350,000 $1,162,500 Deduct: Licensing support revenue $(386,250 ) $(386,250 ) Adjusted Revenue $3,617,078 $4,854,070 Expand The following table reconciles Gross Profit Margin, as reported, to Adjusted Gross Profit Margin for the quarter ended June 30, 2025 vs. June 30, 2024: in US Dollars June 30, 2025 June 30, 2024 Gross Margin as reported $1,849,612 $2,190,607 Add: Cash Receipts from Licensing contracts $1,350,000 $1,162,500 Deduct: Licensing Support Revenue as reported $(386,250 ) $(386,250 ) Adjusted Gross Profit $2,813,362 $2,966,857 Adjusted Gross Profit Margin 78 % 61 % Expand The following table reconciles EBITDA to Adjusted EBITDA for the quarter ended June 30, 2025 vs. June 30, 2024: in US Dollars June 30, 2025 June 30, 2024 EBITDA $(24,168 ) $(445,359 ) Deduct: Licensing support revenue, as reported $(386,250 ) $(386,250 ) Deduct: Licensing revenue interest income, as reported $(153,750 ) $(234,170 ) Add: Cash receipts from licensing agreement, as reported (note 10) $1,350,000 $1,162,500 Adjusted EBITDA $785,822 $96,721 Expand Conference Call Information Date: August 21, 2025 Time: 4:30 PM Eastern Time Toll Free: 888-506-0062 International: 973-528-0011 Participant Access Code: 694542 Webcast URL: Conference Call Replay Information: The replay will be available approximately 1 hour after the completion of the live event. Toll Free: 877-481-4010 International: 919-882-2331 Replay Passcode: 52878 Webcast Replay URL: Financial Reports Full details of the financial and operating results are described in the Company's consolidated financial statements for the three months ended June 30, 2025, with accompanying notes. The consolidated financial statements and additional information about POSaBIT are available on the Company's website at or on SEDAR+ at Non-IFRS Measures Adjusted Revenue, Adjusted Gross Profit (and Adjusted Gross Profit Margin) and Adjusted EBITDA are non-IFRS measures used by management that do not have any prescribed meaning by IFRS and may not be comparable to similar measures presented by other companies. The Company defines Adjusted Revenue as gross revenue, minus license support revenue, plus actual licensing cash received as part of POSaBIT's licensing deals. The Company defines Adjusted Gross Profit as Adjusted Revenue less company cost of goods sold, and Adjusted Gross Profit Margin as a percentage of Adjusted Gross Profit as compared to Adjusted Revenue. The Company defines Adjusted EBITDA as net income or loss generated for the period as reported, before interest, taxes, depreciation and amortization and further adjusted in accordance with the reconciliation table set out in this press release. The Company believes these non-IFRS measures are useful metrics to evaluate its core operating performance and uses these measures to provide shareholders and others with supplemental measures of its operating performance. The Company also believes that securities analysts, investors and other interested parties, frequently use these non-IFRS measures in the evaluation of companies, many of which present similar metrics when reporting their results. We caution readers that Adjusted Revenue, Adjusted Gross Profit (and Adjusted Gross Profit Margin) and Adjusted EBITDA are not substitutes for gross revenue, gross profit or profit/loss, respectively. Forward-Looking Statements This press release contains forward-looking statements, including statements regarding our business strategy, product development, timing of product development, events and courses of action. Statements which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, outlook, expectations or intentions regarding the future including words or phrases such as 'anticipate,' 'objective,' 'may,' 'will,' 'might,' 'should,' 'could,' 'can,' 'intend,' 'expect,' 'believe,' 'estimate,' 'predict,' 'potential,' 'plan,' 'is designed to' or similar expressions suggesting future outcomes or the negative thereof or similar variations. Forward-looking statements may include, among other things, statements about: our expectations regarding annual cost reductions; our expectations regarding rescheduling; the expected recovering of the Company's share price; our future customer concentration; our anticipated cash needs and our estimates regarding our capital requirements; our ability to anticipate the future needs of our customers; our plans for future products and enhancements of existing products; our future growth strategy and growth rate; our future intellectual property; and our anticipated trends and challenges in the markets in which we operate. Such statements and information are based on numerous assumptions regarding present and future business strategies and the environment in which POSaBIT will operate in the future, including the demand for our products, anticipated costs and ability to achieve goals. Although we believe that the assumptions underlying these statements are reasonable, they may prove to be incorrect. Given these risks, uncertainties and assumptions, you should not unduly rely on these forward-looking statements. Forward-looking statements are subject to known and unknown risks, uncertainties and other important factors that may cause the actual results to be materially different from those expressed or implied by such forward-looking statements, including but not limited to, business, economic and capital market conditions; the ability to manage our operating expenses, which may adversely affect our financial condition; our ability to remain competitive as other better financed competitors develop and release competitive products; regulatory uncertainties; market conditions and the demand and pricing for our products; our relationships with our customers, distributors and business partners; our ability to successfully define, design and release new products in a timely manner that meet our customers' needs; our ability to attract, retain and motivate qualified personnel; competition in our industry; our ability to maintain technological leadership; our ability to manage risks inherent in foreign operations; the impact of technology changes on our products and industry; our failure to develop new and innovative products; our ability to successfully maintain and enforce our intellectual property rights and defend third-party claims of infringement of their intellectual property rights; the impact of intellectual property litigation that could materially and adversely affect our business; our ability to manage working capital; and our dependence on key personnel. POSaBIT is an early-stage company; it may not achieve profitability; and it may not actually achieve its plans, projections, or expectations. Important factors that could cause actual results to differ materially from POSaBIT's expectations include consumer sentiment towards POSaBIT's products, litigation, global economic climate, loss of key employees and consultants, additional funding requirements, changes in laws, technology failures, competition, and failure of counterparties to perform their contractual obligations. Neither we nor any of our representatives make any representation or warranty, express or implied, as to the accuracy, sufficiency or completeness of the information in this news release. Neither we nor any of our representatives shall have any liability whatsoever, under contract, tort, trust or otherwise resulting from the use of the information in this news release or for omissions from the information in this news release. ABOUT POSABIT POSaBIT (CSE: PBIT, OTC: POSAF) is a FinTech, working exclusively within the cannabis industry. We provide a best-in-class Point-of-Sale solution and are the leading cashless payment provider for cannabis retailers. We work tirelessly to build better financial services and transaction methods for merchants. We bring cutting-edge software and technology to the cannabis industry so that all merchants can have a safe and compliant set of services to solve the problems of a cash-only industry. For additional information, visit Neither the Canadian Securities Exchange nor the Canadian Investment Regulatory Organization accepts responsibility for the adequacy or accuracy of this release.
Yahoo
4 hours ago
- Yahoo
President Trump Is Considering Rescheduling Cannabis. Is Now the Time to Load Up on Pot Stocks?
Key Points The U.S. government has been looking at potentially rescheduling cannabis for multiple years. Rescheduling could mean that section 280E of the tax code no longer applies. The companies that would primarily benefit from rescheduling are multi-state operators that are already in the U.S. market. 10 stocks we like better than Curaleaf › It's happening again. The cycle of pot stocks surging on news related to potential cannabis reform. It's been a while since the industry has seen so much bullishness, as the vast majority of investors have shunned cannabis in favor of more promising growth investments. Last week, however, pot stocks across the board were rallying. And the big reason was the renewed hope that significant changes could be coming for the cannabis industry. U.S. President Donald Trump is looking at rescheduling cannabis as a less dangerous drug. Nothing is a sure thing yet, but it's a positive development nonetheless. Here's what you need to know. Rescheduling is not the same as legalization or decriminalization Currently, marijuana is classified as a Schedule I substance, putting it in the same category as heroin, LSD, and other harmful substances. Schedule I drugs have "no currently accepted medical use and a high potential for abuse." Given that dozens of states have legalized cannabis for medical use and some countries around the world also permit it for those reasons, its current classification certainly raises more than a few eyebrows. Trump is reportedly looking at rescheduling cannabis to a lower level, possibly Schedule III, which includes testosterone, ketamine, and anabolic steroids. This is not a new development, as there were hopes that reclassification would have taken place under former President Joe Biden. It was back in October 2022 when Biden first asked for the Department of Health and Human Services to review marijuana scheduling. But as with anything related to cannabis, any changes can take a while. The important thing to remember is that while rescheduling cannabis might make it easier to research marijuana, it does not mean that legalizing marijuana is imminent or that even decriminalization is sure to follow. The problem is that, based on how hot pot stocks have been moving recently, investors are acting as if more significant reform is inevitable. Not every cannabis company will directly benefit from rescheduling The biggest near-term win from cannabis rescheduling could be a lower tax bill for marijuana companies. If marijuana were to become classified as a Schedule III drug, then section 280E would no longer apply. This section of the tax code prevents cannabis businesses from deducting ordinary business expenses from their tax returns. Last year, multi-state marijuana operator Curaleaf Holdings (OTC: CURLF) estimated that it would save about $150 million annually due to rescheduling, as a result of the "onerous 280E tax provision" no longer applying. Curaleaf is an example of the type of stock that would benefit from the rescheduling of cannabis. While it wouldn't necessarily open up huge new markets for the business, it would help it achieve some tax savings. Despite being one of the largest cannabis operators in the country, Curaleaf still struggles with both growth and profitability. During the first six months of the year, its revenue was $625 million, down 8% from the same period last year. And its net loss during the past two quarters was $114 million, with Curaleaf's provision for income tax being one of its largest expenses -- $68 million. Shares of Curaleaf rallied last week on recent developments and climbed to more than $3, the highest levels they've reached since last year. But other cannabis stocks also surged, including Canadian-based Tilray Brands (NASDAQ: TLRY). Tilray benefits from being one of the most recognizable cannabis companies in the world as it trades on the Nasdaq exchange. Curaleaf and other multi-state operators aren't able to do so since marijuana isn't federally legal in the U.S. (whereas Canada has legalized the substance). As a result, anytime there is positive pot-related news, Tilray benefits from it, even when it arguably shouldn't. On Aug. 8, Tilray's stock closed at just $0.65, and as of the end of last week, it was at $1.03, soaring by more than 58% in a span of just five trading days -- and that's with it giving back some gains later in the week. Rescheduling cannabis won't enable Tilray to transport products into the U.S. While excitement may be rising around legalization, that is by no means a sure thing. Cannabis stocks are still risky investments Investing in cannabis stocks comes with big risks. The majority of the businesses aren't profitable, and reform in the industry can take a long time. Unless you have both a high risk tolerance and a lot of patience, you may be better off avoiding cannabis stocks entirely. And while there can be significant upside for them in the long run, it's important to remember that not all cannabis companies will benefit from rescheduling, and it's still not a guarantee to happen. Should you buy stock in Curaleaf right now? Before you buy stock in Curaleaf, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Curaleaf wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $671,466!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,115,633!* Now, it's worth noting Stock Advisor's total average return is 1,077% — a market-crushing outperformance compared to 185% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of August 18, 2025 David Jagielski has no position in any of the stocks mentioned. The Motley Fool recommends Nasdaq and Tilray Brands. The Motley Fool has a disclosure policy. President Trump Is Considering Rescheduling Cannabis. Is Now the Time to Load Up on Pot Stocks? was originally published by The Motley Fool Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Business Wire
6 hours ago
- Business Wire
Commerce Bancshares, Inc. Receives Regulatory Approval to Acquire FineMark Holdings, Inc.
KANSAS CITY, Mo.--(BUSINESS WIRE)--Commerce Bancshares, Inc. (NASDAQ:CBSH) ('Commerce'), the holding company for Commerce Bank, announced it has received all regulatory approvals to complete its proposed merger with FineMark Holdings, Inc. (OTC: FNBT) ('FineMark'), the holding company for FineMark National Bank & Trust. The transaction has been approved by the Federal Reserve Bank of Kansas City and the Missouri Division of Finance and remains subject to approval of FineMark shareholders and other customary closing conditions. The transaction is anticipated to close on January 1, 2026, as previously announced. 'We are pleased to have received regulatory approval for our merger with FineMark,' said John Kemper, President and CEO, Commerce Bank. 'This is a significant milestone in bringing our organizations together.' Kemper continued, 'With combined assets of $36 billion and $86 billion in wealth assets under administration, this partnership represents a powerful alignment of cultures, values, and vision. Together, we will have a stronger foundation for growth and will deliver more seamless, innovative, and personalized experiences for our wealth management and private banking clients. This is more than a simple expansion; it's a shared commitment to excellence, growth, and long-term value for our clients, shareholders, and communities.' As of June 30, 2025, FineMark had assets of $3.9 billion, deposits of $3.1 billion and loans of $2.7 billion. FineMark's Trust and Investment business delivers a comprehensive suite of highly personalized services to approximately 2,000 clients with approximately $8.3 billion in assets under administration. ABOUT COMMERCE With $32.3 billion in assets 1, Commerce Bancshares, Inc. (NASDAQ: CBSH) is a regional bank holding company offering a full line of banking services through its subsidiaries, including payment solutions, investment management and securities brokerage. One of its subsidiaries, Commerce Bank, leverages 160 years of proven strength and experience to help individuals and businesses solve financial challenges. In addition to offering payment solutions across the U.S., Commerce Bank currently operates full-service banking facilities across the Midwest including the St. Louis and Kansas City metropolitan areas, Springfield, Central Missouri, Central Illinois, Wichita, Tulsa, Oklahoma City, and Denver. Beyond the Midwest, Commerce also maintains commercial offices in Dallas, Houston, Cincinnati, Nashville, Des Moines, Indianapolis, and Grand Rapids and wealth offices in Dallas, Houston and Naples. Commerce delivers high-touch service and sophisticated financial solutions at regional branches, commercial and wealth offices, ATMs, online, mobile and through a 24/7 customer service line. Learn more at 1 ABOUT FINEMARK FineMark Holdings, Inc. is the parent company of FineMark National Bank & Trust. Founded in 2007, FineMark is a nationally chartered bank and trust company, headquartered in Florida. Through its offices located in Florida, Arizona and South Carolina, FineMark offers a full range of financial services, including personal and business banking, lending, trust and investment services. FineMark's common stock trades on the OTCQX under the symbol FNBT. Investor information is available on FineMark's website at This press release may contain forward-looking statements, including, but not limited to, certain plans, expectations, goals, projections, and statements about the benefits of the proposed business combination transaction between Commerce and FineMark (the 'Proposed Transaction'), the plans, objectives, expectations and intentions of Commerce and FineMark, the expected timing of completion of the Proposed Transaction, and other statements that are not historical facts. All statements other than statements of historical fact, including statements about beliefs and expectations, are forward-looking statements. Forward-looking statements may be identified by words such as 'may,' 'will,' 'should,' 'could,' 'would,' 'plan,' 'potential,' 'estimate,' 'project,' 'believe,' 'intend,' 'anticipate,' 'expect,' 'target' and similar expressions. Forward-looking statements, by their nature, are subject to risks and uncertainties. There are many factors that could cause actual results to differ materially from expected results described in the forward-looking statements. The forward-looking statements are intended to be subject to the safe harbor provided by Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. Factors relating to the Proposed Transaction that could cause or contribute to actual results differing materially from those contained or implied in forward-looking statements or historical performance include, in addition to those factors identified elsewhere in this press release the occurrence of any event, change or other circumstances that could give rise to the right of Commerce or FineMark to terminate the definitive merger agreement governing the terms and conditions of the Proposed Transaction; the outcome of any legal proceedings that may be instituted against Commerce or FineMark; the possibility that revenue or expense synergies or the other expected benefits of the Proposed Transaction may not fully materialize or may take longer to realize than expected, or may be more costly to achieve than anticipated, including as a result of the impact of, or problems arising from, the integration of the two companies, the strength of the economy and competitive factors in the areas where Commerce and FineMark do business, or other unexpected factors or events; the possibility that the Proposed Transaction may not be completed when expected or at all because required shareholder or other approvals or other conditions to closing are not received or satisfied on a timely basis or at all; the risk that Commerce is unable to successfully and promptly implement its integration strategies; reputational risks and potential adverse reactions from or changes to the relationships with the companies' customers, employees or other business partners, including resulting from the announcement or the completion of the Proposed Transaction; the dilution caused by Commerce's issuance of common stock in connection with the Proposed Transaction; diversion of management's attention and time from ongoing business operations and other opportunities on matters relating to the Proposed Transaction; and other factors that may affect the future results of Commerce and FineMark, including continued pressures and uncertainties within the banking industry and Commerce's and FineMark's markets, including changes in interest rates and deposit amounts and composition, adverse developments in the level and direction of loan delinquencies, charge-offs, and estimates of the adequacy of the allowance for loan losses, increased competitive pressures, asset and credit quality deterioration, the impact of proposed or imposed tariffs by the U.S. government or retaliatory tariffs proposed or imposed by U.S. trading partners that could have an adverse impact on customers or any recession or slowdown in economic growth particularly in the markets in which Commerce or FineMark operate, and legislative, regulatory, and fiscal policy changes and related compliance costs. These factors are not necessarily all of the factors that could cause Commerce's or FineMark's actual results, performance, or achievements to differ materially from those expressed in or implied by any of the forward-looking statements. Other unknown or unpredictable factors also could harm Commerce's or FineMark's results. Further information regarding Commerce and factors that could affect the forward-looking statements contained herein can be found in Commerce's Annual Report on Form 10-K for the year ended December 31, 2024 and its Quarterly Reports on Form 10-Q for the quarters ended March 31, 2025 and June 30, 2025, which are accessible on the Securities and Exchange Commission's (the 'SEC') website at and at and in other documents Commerce files with the SEC. Information on these websites is not part of this document. All forward-looking statements attributable to Commerce or FineMark, or persons acting on Commerce's or FineMark's behalf, are expressly qualified in their entirety by the cautionary statements set forth above. Forward-looking statements speak only as of the date they are made and Commerce and FineMark do not undertake or assume any obligation to update publicly any of these statements to reflect actual results, new information or future events, changes in assumptions, or changes in other factors affecting forward-looking statements, except to the extent required by applicable law. If Commerce or FineMark update one or more forward-looking statements, no inference should be drawn that Commerce or FineMark will make additional updates with respect to those or other forward-looking statements. ADDITIONAL INFORMATION AND WHERE TO FIND IT In connection with the Proposed Transaction, Commerce will file with the SEC a Registration Statement on Form S-4 to register the shares of Commerce common stock to be issued in connection with the Proposed Transaction that will include a proxy statement of FineMark and a prospectus of Commerce (the 'proxy statement/prospectus'), as well as other relevant documents concerning the Proposed Transaction. The definitive proxy statement/prospectus will be sent to the shareholders of FineMark seeking their approval of the Proposed Transaction and other related matters. This press release does not constitute an offer to sell or the solicitation of an offer to buy any securities or a solicitation of any vote or approval, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. INVESTORS AND SHAREHOLDERS OF FINEMARK ARE URGED TO READ THE REGISTRATION STATEMENT AND THE PROXY STATEMENT/PROSPECTUS REGARDING THE PROPOSED TRANSACTION WHEN THEY BECOME AVAILABLE AND EACH OTHER RELEVANT DOCUMENT FILED WITH THE SEC BY COMMERCE IN CONNECTION WITH THE PROPOSED TRANSACTION, AS WELL AS ANY AMENDMENTS OR SUPPLEMENTS TO THOSE DOCUMENTS, BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION. Shareholders will be able to obtain a free copy of the definitive proxy statement/prospectus, as well as other filings containing information about the Proposed Transaction, Commerce and FineMark, without charge, at the SEC's website, Copies of the proxy statement/prospectus and the filings with the SEC that will be incorporated by reference in the proxy statement/prospectus can also be obtained, without charge, by directing a request to Commerce's Investor Relations via email at or by telephone at (314) 746-7485, or to FineMark's Investor Relations via email at investorrelations@ or by telephone at (239) 461-3850. Commerce, FineMark and certain of their respective directors and executive officers may be deemed to be participants in the solicitation of proxies from the shareholders of FineMark in connection with the Proposed Transaction under the rules of the SEC. Information regarding Commerce's directors and executive officers is available in the sections entitled 'Directors, Executive Officers and Corporate Governance' and 'Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters' in Commerce's Annual Report on Form 10-K for the fiscal year ended December 31, 2024, which was filed with the SEC on February 25, 2025 (available at in the sections entitled 'Security Ownership of Certain Beneficial Owners and Management,' 'Composition of the Board, Board Diversity and Director Qualifications,' 'Corporate Governance' 'Compensation Discussion and Analysis' and 'Executive Compensation,' in Commerce's definitive proxy statement relating to its 2025 Annual Meeting of Shareholders, which was filed with the SEC on March 14, 2025 (available at and other documents filed by Commerce with the SEC. To the extent holdings of Commerce common stock by the directors and executive officers of Commerce have changed from the amounts held by such persons as reflected in the documents described above, such changes have been or will be reflected on Statements of Change in Ownership on Form 4 filed with the SEC. Additional information regarding the participants in the proxy solicitation and a description of their direct and indirect interests, by security holdings or otherwise, will be contained in the proxy statement/prospectus relating to the Proposed Transaction. Free copies of this document may be obtained as described in the preceding paragraph.
